Lumenis has announced the formation of its inaugural Ophthalmology Advisory Board, bringing together five ophthalmologists to help guide the development of technologies for dry eye disease, ocular surface disease, and other ophthalmic applications.

The board will provide clinical expertise and strategic guidance to support Lumenis' technology development and help align its ophthalmic solutions with evolving patient and physician needs.

Advisory Board Members

- Neel Desai, MD, of The Eye Institute of West Florida, has helped advance interventional dry eye treatment and co-authored a randomized controlled trial evaluating intense pulsed light therapy for meibomian gland dysfunction.

- Mina Massaro-Giordano, MD, director of the Dry Eye Service at NYU Langone Eye Center, has more than 25 years of experience researching dry eye disease, including its neural and inflammatory mechanisms.

- Kendall Donaldson, MD, Rodgers Clark Endowed Chair in Ophthalmology and professor of clinical ophthalmology at Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, specializes in corneal and anterior segment care.

- Jai Parekh, MD, co-founder of EyeCare Consultants of NJ, specializes in ocular surface disease, dry eye, cornea, cataract, and glaucoma. He also holds clinical leadership positions at St. Joseph's Health System.

- Eric Gerschenbaum, MD, of the Witlin Center for Advanced Eye Care in New Jersey, has more than 20 years of experience in cataract and refractive surgery.